Litcius/Paper detail

Blood viscosity of COVID-19 patient: a preliminary report.

Beuy Joob, Viroj Wiwanitkit

2021PubMed46 citationsOpen Access PDF

Abstract

COVID-19 is the important global problem. This new coronavirus can cause several hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19, thrombosis might be the result of endothelial dysfunction, platelet activation, increasd blood viscosity, and blood flow disturbance. The change of blood viscosity in the patients with COVID-19 is possible but little mentioned. Here, the authors report on a preliminary data on blood viscosity assessment among 41 COVID-19 patients. According to the estimation, the estimated blood viscosity values are 72.4 ± 18.6 and 18.2 ± 2.2 for high and low shear rates. Based on this preliminary report, the increased blood viscosity is detected in COVID-19 patient and it might be associated with thrombohemostatic problem.

Topics & Concepts

MedicineBlood viscosityCoronavirus disease 2019 (COVID-19)ThrombosisBlood flowViscosity2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusPlateletCardiologyInternal medicinePlatelet activationIntensive care medicinePathologyOutbreakDiseasePhysicsInfectious disease (medical specialty)Quantum mechanicsBlood properties and coagulationCOVID-19 Clinical Research StudiesDermatological and COVID-19 studies